4 transcripts
ABBV
Earnings call transcript
NYSE
2024 Q2
25 Jul 24
, this level of market growth was lower than previously anticipated. Sales for BOTOX Cosmetic and JUVEDERM also benefited from a partial reversal
ABBV
Earnings call transcript
NYSE
2024 Q1
26 Apr 24
quarter of last year, which benefited from a robust recovery post COVID. We are monitoring the economic developments across China and continue
ABBV
Earnings call transcript
NYSE
2023 Q4
2 Feb 24
, representing an operational increase of 9%. We experienced strong performance in most regions and growth benefited from the impact of China's COVID
ABBV
Earnings call transcript
NYSE
2023 Q2
27 Jul 23
half. In the third quarter, we will be facing a challenging year-over-year comparison due to a shipment timing benefit we saw in the third quarter
- Prev
- 1
- Next